Inactive Instrument

Other languages Therma Bright Inc Toronto S.E.

Equities

JEN.H

CA4760231064

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	06-28
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	04-01
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	01-09
Therma Bright Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	01-04
Therma Bright Prepares Fda 513(G) Review Therma Bright Prepares FDA 513(G) Review Analyzer	11-29
Therma Bright Inc. Announces Venowave Pilot Tests with Existing and New Distribution Partners in the United States	11-02
Therma Bright Inc Signs Hero Lifecare to A U.S. Distribution Partner for Marketing and Selling the Venowave Device	23-09-13
Therma Bright Inc. Submits Updated FDA 510K Application Requesting Correction of Venowave Device's Intended Use, Labeling, and Description	23-09-07
Therma Bright Inc. Provides Update on Venowave for the United States and Texas Region	23-06-30
Therma Bright Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-28
Therma Bright Inc.: Therma Bright prüft die Kostenerstattung für die therapeutische Fernüberwachung für seine KI-basierte Digital Cough-Technologie	23-06-23
Therma Bright Inc. and Inretio Inc. Announces Successful Completion of Good Laboratory Practice Study for Its Breakthrough Preva™? Mechanical Thrombectomy Device	23-06-07
Therma Bright Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-04-03
Therma Bright Inc.: Therma Brights Investmentpartner Inretio übersiedelt in eine neue Produktionsanlage	23-03-08
Therma Bright Inc.: Therma Bright gibt die Ernennung von Dr. John Patton als Chairman der Beteiligungsfirma InStatin Inc. bekannt	23-03-01
Therma Bright Inc. Provides an Update on Its Partnership with Inretio Inc	23-02-23
Therma Bright Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-23
Therma Bright investiert in die entwicklung neuartiger behandlungen für COVID-19, asthma und chronisch obstruktive lungenerkrankung (COPD)	22-12-02
Therma Bright investiert in die entwicklung neuartiger behandlungen für COVID-19, asthma und chronisch obstruktive lungenerkrankung (COPD)	22-12-02
Therma Bright investiert in die entwicklung neuartiger behandlungen für COVID-19, asthma und chronisch obstruktive lungenerkrankung (COPD)	22-12-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Therma Bright Inc Toronto S.E.

Equities

JEN.H

CA4760231064

Other languages

Filters